The Indian geriatric medicine market is projected to grow at a significant CAGR of 8.1% during the forecast period. The Government of India has been focusing on issues, such as maternal and child health, population stabilization, and elderly health. There elderly people in India face medical and socio-economic problems, owing to which, the Government of India is planning and strategizing for bringing about an improvement in the healthcare facility for the geriatric population. In India, the elderly people suffer from dual medical problems, namely communicable and non–communicable diseases. This is further compounded by the weakening of special sensory functions, such as vision and hearing.
A full report of India Geriatric Medicine Market is available at: https://www.omrglobal.com/industry-reports/india-geriatric-medicine-market
A decline in immunity and age-related physiologic changes leads to an increased burden of communicable diseases in the geriatric population. The National Programme for Health Care of the Elderly (NPHCE) is an enunciation of the International and national commitments of the Government as envisioned under the UN Convention on the Rights of Persons with Disabilities (UNCRPD), National Policy on Older Persons (NPOP) adopted by the Government of India in 1999 and Section 20 of “The Maintenance and Welfare of Parents and Senior Citizens Act, 2007” dealing with provisions for medical care of Senior Citizen.
To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/india-geriatric-medicine-market
Market Coverage
- Study Period- 2019-2026
- Base year- 2019
- Forecast period- 2020-2026
- Segments Covered- By Therapeutics and By Condition
- Key Companies Profiled- Aurobindo Pharma Ltd. Mankind Pharma, Cipla Ltd., Sun Pharmaceuticals Industries Ltd., and Johnson & Johnson Services Inc.
Key questions addressed by the report
- What is the market growth rate during the forecast period?
- Which segment dominates the market in the base year?
- Which segment will project the fastest growth in the market during the forecast period?
- How COVID-19 will impact the market growth in 2020 and coming years?
o Recovery Timeline
o Deviation from pre-COVID-19
o Most affected segment
o Recommendations
- Who is the leader in the market?
- How players are addressing challenges to sustain growth?
- Where is the investment opportunity?
India Geriatric Medicine Market – Segmentation
By Therapeutics
- Analgesic
- Anticoagulant
- Antihypertensive
- Antidiabetic
- Others (Statins and Antipsychotic)
By Condition
- Cardiovascular Diseases (CVDs)
- Diabetes
- Neurological
- Cancer
- Respiratory
- Others (Arthritis and Osteoporosis)
This release has been published on OMR Industry Journal. OMR Industry Journal is not responsible for any content included in this release.
